BioCentury | Feb 18, 2021
Finance

With $300M fund, Adjuvant picks its spots among start-ups addressing global public health needs

...CRISPR gene editing to create curative antiviral therapies, including programs for HIV, HBV and herpes simplex...
BioCentury | Feb 18, 2021
Finance

Eyeing functional cure, Excision raises $60M to advance CRISPR-based HIV program into Phase I/II

...The funds will also support preclinical programs EBT-103 for progressive multifocal leukoencephalopathy, EBT-104 for herpes simplex...
BioCentury | Jan 30, 2021
Distillery Therapeutics

Autophagy-activating gene therapy to treat recurrent HSV-2 infection

...By Claire Quang, Staff Writer DISEASE CATEGORY: Infectious diseaseINDICATION: Herpes simplex virus (HSV); meningitisGene therapies correcting...
...published online Dec. 11, 2020doi:10.1126/sciimmunol.abc2691CONTACT: Trine H. Mogensen, Aarhus University Hospital, Aarhus, Denmarkemail: trine.mogensen@biomed.au.dk Claire Quang Aarhus University Hospital Infectious Meningitis Herpes simplex...
BioCentury | Oct 2, 2020
Distillery Therapeutics

Targeting CXCL1 signaling for HSV-1 encephalitis

...By Claire Quang, Staff Writer DISEASE CATEGORY: Infectious diseaseINDICATION: Encephalitis; herpes simplex virus (HSV)Inhibiting CXCL1 or its...
...Hospital Harvard Medical School Chemokine CXC motif ligand 1 (CXCL1) (GRO) (MGSA) CXC chemokine receptor 2 (CXCR2) (IL8RB) Infectious Encephalitis Herpes simplex...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...the International Symposium on NeuroVirology meeting in Atlanta showing CRISPR-Cas9 gene editing could treat herpes simplex...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...candidate, ONCR-177, into Phase I testing for solid tumors. The product uses the company’s herpes simplex...
BioCentury | Aug 8, 2019
Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

...response rate from 18% to 38.8% compared with Yervoy alone. Amgen gained Imlygic, a herpes simplex...
...Takara Bio Inc. (JASDAQ:4974) Otsuka Pharmaceutical Co. Ltd. Intratumorally delivered unmodified, attenuated strain of herpes simplex...
BioCentury | Aug 5, 2019
Clinical News

Aug. 5 Clinical Quick Takes: Emgality meets for migraine with treatment failures; plus Verona, Alkahest-Grifols, Squarex and Denali-Sanofi

...LLC Verona Pharma plc Calcitonin gene-related peptide (CGRP) Phosphodiesterase-3 (PDE-3) Phosphodiesterase-4 (PDE-4) Receptor-interacting serine-threonine kinase 1 (RIPK1) (RIP1) Alzheimer's disease (AD) Herpes simplex...
BioCentury | Aug 2, 2019
Clinical News

SillaJen, Transgene fall with latest oncolytic virus setback

...interest in the field. Like Pexa-Vec, T-Vec delivers GM-CSF, but the vaccine is a herpes simplex...
BioCentury | Jun 5, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2019

...E3 (VEEV E3) VEEV capsid protein (VEEV C) VEEV 6K protein (VEEV 6K) Encephalitis; herpes simplex...
Items per page:
1 - 10 of 648
BioCentury | Feb 18, 2021
Finance

With $300M fund, Adjuvant picks its spots among start-ups addressing global public health needs

...CRISPR gene editing to create curative antiviral therapies, including programs for HIV, HBV and herpes simplex...
BioCentury | Feb 18, 2021
Finance

Eyeing functional cure, Excision raises $60M to advance CRISPR-based HIV program into Phase I/II

...The funds will also support preclinical programs EBT-103 for progressive multifocal leukoencephalopathy, EBT-104 for herpes simplex...
BioCentury | Jan 30, 2021
Distillery Therapeutics

Autophagy-activating gene therapy to treat recurrent HSV-2 infection

...By Claire Quang, Staff Writer DISEASE CATEGORY: Infectious diseaseINDICATION: Herpes simplex virus (HSV); meningitisGene therapies correcting...
...published online Dec. 11, 2020doi:10.1126/sciimmunol.abc2691CONTACT: Trine H. Mogensen, Aarhus University Hospital, Aarhus, Denmarkemail: trine.mogensen@biomed.au.dk Claire Quang Aarhus University Hospital Infectious Meningitis Herpes simplex...
BioCentury | Oct 2, 2020
Distillery Therapeutics

Targeting CXCL1 signaling for HSV-1 encephalitis

...By Claire Quang, Staff Writer DISEASE CATEGORY: Infectious diseaseINDICATION: Encephalitis; herpes simplex virus (HSV)Inhibiting CXCL1 or its...
...Hospital Harvard Medical School Chemokine CXC motif ligand 1 (CXCL1) (GRO) (MGSA) CXC chemokine receptor 2 (CXCR2) (IL8RB) Infectious Encephalitis Herpes simplex...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...the International Symposium on NeuroVirology meeting in Atlanta showing CRISPR-Cas9 gene editing could treat herpes simplex...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...candidate, ONCR-177, into Phase I testing for solid tumors. The product uses the company’s herpes simplex...
BioCentury | Aug 8, 2019
Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

...response rate from 18% to 38.8% compared with Yervoy alone. Amgen gained Imlygic, a herpes simplex...
...Takara Bio Inc. (JASDAQ:4974) Otsuka Pharmaceutical Co. Ltd. Intratumorally delivered unmodified, attenuated strain of herpes simplex...
BioCentury | Aug 5, 2019
Clinical News

Aug. 5 Clinical Quick Takes: Emgality meets for migraine with treatment failures; plus Verona, Alkahest-Grifols, Squarex and Denali-Sanofi

...LLC Verona Pharma plc Calcitonin gene-related peptide (CGRP) Phosphodiesterase-3 (PDE-3) Phosphodiesterase-4 (PDE-4) Receptor-interacting serine-threonine kinase 1 (RIPK1) (RIP1) Alzheimer's disease (AD) Herpes simplex...
BioCentury | Aug 2, 2019
Clinical News

SillaJen, Transgene fall with latest oncolytic virus setback

...interest in the field. Like Pexa-Vec, T-Vec delivers GM-CSF, but the vaccine is a herpes simplex...
BioCentury | Jun 5, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2019

...E3 (VEEV E3) VEEV capsid protein (VEEV C) VEEV 6K protein (VEEV 6K) Encephalitis; herpes simplex...
Items per page:
1 - 10 of 648